GLP ‐1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation
Key Points
This research aims to examine the consumption patterns, safety, and regulation of GLP-1 receptor agonists in Brazil.
Analysis of market trends and consumption data
Assessment of regulatory frameworks
Evaluation of safety reports and incidents
Investigation of off-label usage
Significant demand increases for GLP-1 receptor agonists noted.
Widespread off-label use raises safety concerns.
Product falsification incidents documented.
Access disparities primarily linked to economic factors.
Abstract
The convergence of escalating demand, widespread off-label use and product falsification requires a coordinated and agile regulatory response. The observed trends suggest significant access disparities driven by economic factors rather than epidemiological need.